Early-phase administration of human amnion-derived stem cells ameliorates neurobehavioral deficits of intracerebral hemorrhage by suppressing local inflammation and apoptosis

BACKGROUND: Intracerebral hemorrhage (ICH) is a significant cause of death and disabilities. Recently, cell therapies using mesenchymal stem cells have been shown to improve ICH-induced neurobehavioral deficits. Based on these findings, we designed this study to evaluate the therapeutic efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuramoto, Yoji, Fujita, Mitsugu, Takagi, Toshinori, Takeda, Yuki, Doe, Nobutaka, Yamahara, Kenichi, Yoshimura, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840774/
https://www.ncbi.nlm.nih.gov/pubmed/35151317
http://dx.doi.org/10.1186/s12974-022-02411-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840774/
https://www.ncbi.nlm.nih.gov/pubmed/35151317
http://dx.doi.org/10.1186/s12974-022-02411-3

Ejemplares similares